Summary
- Current Price
- As of today, CYCN price is $23.94
- Current Price All-Time High
- CYCN price is currently -99.25% below its historical high of $3,199.00 set on
- Market Cap
- CYCN current market cap is $16M, down -68.22% year-over-year
- Revenue
- CYCN current annual revenue is $2.07M, up +3.70% year-over-year
- Next Earnings
- As of today, the next earnings release for CYCN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cyclerion Therapeutics, Inc. |
| Ticker | NASDAQ: CYCN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cyclerion.com |
| Employees | 1 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $23.94 | ||
| Price, 1D Change | - | |
| $16M | ||
| - | ||
| - | ||
| 2.24 | ||
| $2.07M | ||
| Revenue, 1Y Change | +3.70% | |
| -$1.11 | ||
| EPS, 1Y Change | +8.65% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.11 | ||
| EPS Estimate | -$8.40 | N/A |
| EPS Est. Change | -657.37% | N/A |
| $2.07M | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $23.94 | ||
| Price Target | $56.00 | - |
| Price Tgt. Change | +133.92% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.21 | - | |
| -$1.34 | -$1.11 | +17.23% | |
| -$8.40 | N/A | -657.37% | |
| -$6.93 | N/A | -524.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $2.00M | - | |
| $1.10M | $2.07M | +88.55% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +46.15% | ||
| -12.31% | ||
| -68.22% | ||
| -75.64% | ||
| +3.70% | ||
| +598.32% | ||
| +8.65% | ||
| +94.53% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $23.94 | ||
| $17.92 | ||
| $26.24 | ||
| $21.01 | ||
| $26.26 | ||
| $0.85 | ||
| 2.24 | ||
| $3.56 | ||
| 41.98 | ||
| 166.59% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.07M | ||
| -$1.11 | ||
| $0.00 | ||
| 0.00% | ||
| -$4.97M | ||
| -239.78% | ||
| -$3.53M | ||
| -170.11% | ||
| -$4.97M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 5.15 | ||
| 5.15 | ||
| - | ||
| - | ||
| -28.31 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 8.43 | ||
| 3.15 | ||
| -2.14 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $9.09M | ||
| $3.24M | ||
| $9.99M | ||
| $4.64M | ||
| $900.00K | ||
| $900.00K | ||
| $0.00 | ||
| $0.00 | ||
| $508.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $5.60M | ||
| $4.97M | ||
| - | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$3.31M | ||
| $0.00 | ||
| $3.32M | ||
| $0.00 | ||
| -$3.31M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
No data
Screeners with CYCN
FAQ
- What is the ticker symbol for Cyclerion Therapeutics, Inc.?
- The ticker symbol for Cyclerion Therapeutics, Inc. is NASDAQ:CYCN
- Does Cyclerion Therapeutics, Inc. pay dividends?
- No, Cyclerion Therapeutics, Inc. does not pay dividends
- What sector is Cyclerion Therapeutics, Inc. in?
- Cyclerion Therapeutics, Inc. is in the Healthcare sector
- What industry is Cyclerion Therapeutics, Inc. in?
- Cyclerion Therapeutics, Inc. is in the Biotechnology industry
- What country is Cyclerion Therapeutics, Inc. based in?
- Cyclerion Therapeutics, Inc. is headquartered in United States
- When did Cyclerion Therapeutics, Inc. go public?
- Cyclerion Therapeutics, Inc. initial public offering (IPO) was on March 18, 2019
- Is Cyclerion Therapeutics, Inc. in the S&P 500?
- No, Cyclerion Therapeutics, Inc. is not included in the S&P 500 index
- Is Cyclerion Therapeutics, Inc. in the NASDAQ 100?
- No, Cyclerion Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Cyclerion Therapeutics, Inc. in the Dow Jones?
- No, Cyclerion Therapeutics, Inc. is not included in the Dow Jones index
- When was Cyclerion Therapeutics, Inc. last earnings report?
- Cyclerion Therapeutics, Inc.'s most recent earnings report was on November 14, 2025
- When does Cyclerion Therapeutics, Inc. report earnings?
- The date for Cyclerion Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CYCN Official Website www.cyclerion.com
- CYCN Profile on Yahoo Finance finance.yahoo.com/quote/CYCN
- CYCN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cycn